Thu, December 2, 2021

Matthew Biegler Initiated (VOR) at Buy and Held Target at $30 on, Dec 2nd, 2021

Matthew Biegler of Oppenheimer, Initiated "Vor Biopharma Inc." (VOR) at Buy and Held Target at $30 on, Dec 2nd, 2021.

Matthew has made no other calls on VOR in the last 4 months.



There is 1 other peer that has a rating on VOR. Out of the 1 peers that are also analyzing VOR, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Silvan Tuerkcan of "JMP Securities" Initiated at Buy and Held Target at $40 on, Tuesday, October 19th, 2021